Pregnancy: (3) Drug use in pregnancy: Part 1

Pharmaceutical Journal

Volumn 270, Issue 7237, 2003, Pages 270-272

  McElhatton, Patricia R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; INSULIN; LABETALOL; LISINOPRIL; LOSARTAN; MAGNESIUM SULFATE; METFORMIN; METHYLDOPA; METOPROLOL; NIFEDIPINE; ORAL ANTIDIABETIC AGENT; PINDOLOL; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TIMOLOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT; VALSARTAN; VERAPAMIL;

ANURIA; ARTICLE; BLOOD GLUCOSE MONITORING; DEPRESSION; DRUG CHOICE; DRUG OVERDOSE; DRUG USE; FETUS; FETUS MONITORING; HIGH RISK PREGNANCY; HUMAN; HYPOTENSION; INSULIN RELEASE; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; OBSTETRIC CARE; OLIGOHYDRAMNIOS; PERINATAL DRUG EXPOSURE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; TERATOGENICITY; TREATMENT CONTRAINDICATION;

EID: 0037460495     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sibia BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100:369-77.
2. De Swiet M, editor. Medical disorders in obstetric practice. 4th edition. Oxford: Blackwell Science; 2002.
3. McElhatton P. Heart and circulatory system drugs. In: Schaefer Ch, editor. Drugs during pregnancy and lactation. Amsterdam: Elsevier; 2001. pp116-31.
4. McElhatton P. Teratogenic drugs - part 2. Adverse Drug Reactions Bulletin 2002; No 214: 819-22.
5. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 5th edition. Baltimore: Williams and Wilkins; 1998.
6. Cockburn J, Moar VA, Ounsted M, Redman CWG: Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;2:647-9.
7. Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999;12:541-7.
8. Scialli A, Rost van Tonningen M. Hormones. In: Schaefer Ch, editors. Drugs during pregnancy and lactation. Amsterdam: Elsevier; 2001. pp132-148.
9. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 2002;325: 1275-6.
10. Garbis H, McElhatton PR, Psychotrophic, sedative-hypnotic and parkinson drugs. In: Schaefer C, editors. Drugs during pregnancy and lactation. Amsterdam: Elsevier; 2001. pp182-91.
11. Gold LH. Treatment of depression during pregnancy. J Women's Health and Gender-Base Medicine 1999;8:601-7.
12. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones K. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5.
13. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JGW, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62.